Cite
HARVARD Citation
Solh, M. et al. (2021). A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies. Advances in hematology. p. . [Online].